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Abstract
Listeria monocytogenes infection during pregnancy can lead to dramatic fetal or neonatal outcomes. No clinical trial has evaluated treatment
options, and retrospective studies of cases are therefore important to deﬁne optimal regimens. We report four cases of materno–neonatal
listeriosis illustrating inadequate antimicrobial therapy management and discuss recommended treatment options.
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Introduction
Listeria monocytogenes is a gram-positive bacillus responsible for
listeriosis, a rare yet potentially severe food-borne infection
[1] . Pregnant women are at particularly high risk for invasive
listeriosis, with mild or even asymptomatic maternal presen-
tation contrasting with the potentially dramatic fetal or
neonatal outcomes, including abortion, stillbirth, preterm birth
and severe neonatal infection [2]. Fetal or neonatal loss occurs
in 20% of cases [3].
Prevention in pregnant women relies on adherence to strict
diet recommendations such as reheating of leftovers until
steaming and avoidance of unpasteurized dairy products, cold
delicatessen items, meat spreads and pa^tes [http://www.cdc.
gov/Listeria/prevention.html 1999].
Early diagnosis remains challenging: 30% of infected mothers
are asymptomatic and blood cultures are positive in only 36%
of symptomatic mothers [3]. Treatment recommendations are
based on in vitro and in vivo experimental studies, and
heterogeneous historical cohorts [3]. Amoxicillin is the
keystone of listeriosis treatment and should be swiftly
prescribed when L. monocytogenes is isolated during pregnancy.
In addition, some experts recommend empiric amoxicillin
therapy in the presence of high-level clinical suspicion, without
consensus on treatment dosage and duration [4]. In the
absence of clinical trials addressing this issue, retrospective
studies of cases are instrumental in clarifying the situations
requiring antibiotics, optimal regimen, dosage and duration [5].
We report four cases of pregnancy-associated listeriosis with
inadequate antibiotic therapy to help in deﬁning optimal
treatment options.
Patients and Methods
Surveillance of human listeriosis in France is based on
mandatory reporting of cases and voluntary submission of
L. monocytogenes isolates to the French National Reference
Centre (NRC) for Listeria. We deﬁned a case of preg-
nancy-associated listeriosis as L. monocytogenes isolation from
a pregnant woman, her fetus, or from a newborn <28 days
old. All 146 pregnancy-associated cases reported to the NRC,
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including those included in the prospective national study
conducted by the NRC (MONALISA, Clinical trials
NCT01520597) from January 2009 to September 2012, were
reviewed: those who reported fever or who had received
antimicrobial therapy before listeriosis were identiﬁed and
their medical records were analysed. Four cases with medical/
obstetric conditions compatible with listeriosis were
retrieved and presented here. Isolates were identiﬁed as




A 37-year-old G8P4 (gestations 8, parity 4) obese pregnant
woman from Cameroon presented with genital hemorrhage
at 33 weeks of gestation. Medical history included three
spontaneous abortions and myomectomy by laparoscopy. She
was afebrile and blood pressure was normal. Endocervical
bleeding was evidenced, without evidence for placenta praevia
or placental abruption. Vaginal swab and urine samples
evidenced no pathogen. C-reactive protein (CRP) was
13 mg/L. No blood culture was performed. Bleeding sponta-
neously waned and she was discharged with amoxicillin 3 g/
day for 5 days according to local protocols for genital
haemorrhages. At 37 weeks of gestation she gave birth by
cesarean section (uterus scar) to a eutrophic male baby.
Infant clinical examination and placenta macroscopic aspect
were normal. Meconium culture yielded numerous colonies
of L. monocytogenes. Infant blood culture was sterile and his
CRP <1 mg/L. He was treated with intravenous amoxicillin
100 mg/kg/day for 7 days and gentamicin for 2 days. His
clinical examination and CRP level remained normal, stool
cultures remained negative for L. monocytogenes and he was
discharged home.
Case 2
A 35-year-old G1P0 pregnant woman without medical history
presented with fever (38.5°C) at 29 weeks of gestation.
Cervical and fetal assessments were unremarkable. No focal
infection was found. Leucocytosis was 20 9 109/L, CRP was
50 mg/L, vaginal swab found no pathogen. Blood cultures grew
L. monocytogenes, for which oral amoxicillin 3 g/day was
prescribed for 5 days, followed by cefpodoxime 200 mg twice
a day for a further 5 days. She became afebrile and was
discharged home. She consulted at 31 weeks of gestation for
fever and uterine contractions, and gave birth prematurely to a
female eutrophic baby whose gastric aspiration, placenta and
blood cultures were positive for L. monocytogenes. Infant
lumbar puncture was haemorrhagic. Ultrasound brain imaging
displayed ventriculitis consistent with meningitis. Maternal
vaginal swab and urine sample tested positive for L. monocyt-
ogenes. The infant received intravenous amoxicillin 200 mg/kg/
day for 21 days and tobramycin for 5 days, with favourable
outcome.
Case 3
A 24-year-old G1P0 pregnant woman presented with fever
(38°C), uterine contractions and vomiting at 34 weeks of
gestation. Medical history included smoking cessation and
nephrolithiasis. At examination no focal infection, vaginal
discharge or rupture of membranes was found. Cervical and
fetal assessments were unremarkable. Vaginal swab and urine
sample cultures were sterile. No blood culture was per-
formed. Renal and urinary tract ultrasonography was normal.
Leucocytosis was 8.2 9 109/L, CRP was 25 mg/L and liver
function tests were normal. She was discharged with ceﬁxime
200 mg twice daily for 7 days. At 36 weeks of gestation she
consulted for fever (38°C) and uterine contractions. Leuco-
cytosis was 20 9 109/L and CRP was 36 mg/L. She prema-
turely gave birth by vaginal delivery to a female febrile (38°C)
eutrophic baby who presented respiratory failure. Amniotic
ﬂuid was meconium-stained. Gastric aspirate, ear swabs, blood
culture and cerebrospinal ﬂuid all yielded L. monocytogenes.
The baby was successfully treated with amoxicillin 200 mg/kg/
day for 21 days.
Case 4
A 35-year-old G8P3 pregnant woman from Cameroon
presented with fever (38°C), vomiting and diarrhoea at
29 weeks of gestation. She was human immunodeﬁciency
virus (HIV) -infected (CD4+ T-cell blood count 577/mm3, HIV
viral load < 20 copies/mL) and her antiretroviral regimen
included tenofovir, emtricitabine and lopinavir/ritonavir. Fetal
assessment was normal. Vaginal swab evidenced no pathogen;
stool, urine and blood samples cultured negative. Leucocytosis
was 5.2 9 109/L, CRP was 47 mg/L. She was discharged
without antimicrobial therapy and her symptoms resolved. At
38 weeks of gestation, she was admitted to the emergency
room for fever and uterine contractions. She gave birth by
cesarean section to a male eutrophic baby whose clinical
examination was normal. Maternal blood cultures grew
L. monocytogenes and urine cultures were negative. The
mother received intravenous amoxicillin 8 g/day for 14 days
and gentamicin for 2 days, with good outcome. Newborn
blood, ear swab, placenta and gastric aspiration samples
cultured negative. The baby received amoxicillin 100 mg/kg/
day for 6 days and gentamicin for 3 days. He remained
asymptomatic and HIV-negative.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, 246–249
CMI Charlier et al. Listeriosis during pregnancy, treatment failures 247
Discussion
These observations present an array of maternal clinical
situations that ended in overt neonatal listeriosis (cases 2–4)
or neonatal L. monocytogenes colonization (case 1). Together,
they illustrate that maternal listeriosis optimal treatment
requires the recognition of maternal clinical settings evocative
of listeriosis and the timely prescription of an active drug,
amoxicillin, at the right dose and time and for adequate
duration (above 3 g/day, for more than 5 days).
Cases 1, 3 and 4 were documented postnatally, without
direct assessment of maternal infection. Case 3 in particular,
although febrile, had no blood cultures collected. Maternal
clinical presentation of cases 3 and 4 was evocative of
listeriosis, although the 9-week delay between gastrointesti-
nal symptoms and premature birth in case 4 was higher than
the median incubation time reported in pregnancy [6]. In
case 1, the link between isolated genital haemorrhage and
maternal listeriosis remains unclear; however, the excep-
tional observation of L. monocytogenes in the ﬁrst meconium
without neonatal systemic infection suggests, although it does
not demonstrate, an incomplete effect of maternal
amoxicillin.
When to treat?
Early diagnosis and therapy are the cornerstone of listeriosis
management. Available recommendations favour empirical
treatment in high-risk situations [4], such as fever during
labour, preterm labour or uterine irritability, especially during
an ongoing listeriosis outbreak [7]. Other local practices, such
as in France—where public health authorities dealt in the
mid-1990s with repeated listeriosis outbreaks and numerous
sporadic cases—consider amoxicillin in each case of unex-
plained fever during pregnancy to prevent overt listeriosis
[7,8]. The relevance of this practice is debated. Pros include
the delayed and low frequency of positive maternal blood
cultures in maternal listeriosis [3], the potentially severe
outcome of untreated listeriosis, and the efﬁcacy of prompt
therapy [9]. Cons include the unevaluated cost-effectiveness
of this strategy given the low incidence of pregnancy-associ-
ated listeriosis against the high incidence of undocumented
fever during pregnancy—in 2011, 31 cases of pregnancy-asso-
ciated listeriosis were reported to the French NRC for a total
of c.800 000 live births during the same period—the risk of
antibiotic adverse effects (allergy), the ineffectiveness of
amoxicillin on other common and potentially severe bacterial
infections (Enterobacteriaceae), and the selection of resistant
enteric bacteria possibly transmitted to the neonate. These
reports highlight situations of L. monocytogenes suspicion that
would have or did beneﬁt from adequate diagnosis strategy
based on blood cultures and swift empiric treatment:
unexplained isolated fever (case 2), fever with gastrointestinal
symptoms and uterine contractions (cases 3 and 4). Listeri-
osis, although rare, should be kept in mind along with other
febrile diseases requiring speciﬁc therapies: gastroenteritis,
inﬂuenza or ﬂu-like infections, pyelonephritis, chorioamnioni-
tis. In case of fever, blood cultures should be performed.
How to treat?
First, when empiric therapy is decided, active antimicrobials
should be chosen, unlike cases 2 and 3 who received
cephalosporin to which L. monocytogenes is naturally resistant
[1]. Recommended dosage is mostly based on L. monocytog-
enes meningitis treatment recommendations [5] and ranges
from 3 to 12 g/day for 7–28 days, or even until delivery
[4,10,11]. French recommendations rely on amoxicillin
100 mg/kg/day for 2 weeks, associated with gentamicin
5 mg/kg/day for 3 to 5 days [8]. Cases 1 and 2 suggest that
high-dose (>3 g/day) and prolonged (>5 days) therapy are
needed for cure. These mothers received amoxicillin 3 g/day
for 5 days, which turned out to be ineffective for case 2, and
partly ineffective for case 1, where L. monocytogenes was
cultured from meconium, without overt infection. Gentamicin
is synergic with amoxicillin and could have been added in case
2 [5].
In conclusion, these cases illustrate that L. monocytogenes
should be kept in mind as a cause of unexplained fever during
pregnancy; they provide data that underline the beneﬁt of early
adequate empiric therapy in well-chosen situations, and the
need for high-dose prolonged amoxicillin therapy. Data from
larger cohorts are needed to clarify optimal L. monocytogenes
therapy in pregnancy.
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